mRNA |
ABT-888 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.03 |
mRNA |
piperlongumine:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.03 |
mRNA |
YM-155 |
CTRPv2 |
pan-cancer |
AAC |
0.08 |
0.03 |
mRNA |
NVP-BEZ235 |
GDSC1000 |
pan-cancer |
AAC |
0.073 |
0.03 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
TW 37 |
GDSC1000 |
pan-cancer |
AAC |
0.069 |
0.03 |
mRNA |
KHS101 |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.07 |
0.03 |
mRNA |
JNJ-26854165 |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.03 |